Guidance

Avian influenza: PGD templates

Patient group direction (PGD) templates for the supply of oseltamivir for pre and post exposure prophylaxis of avian influenza (flu).

From:
UK Health Security Agency
Published
12 January 2016
Last updated
20 December 2021 — See all updates

Documents

PGD for the supply of oseltamivir for pre and post exposure prophylaxis of non-H7N9 avian influenza in adults and children aged one year or older

Ref: UKHSA publications gateway number GOV-10648

MS Word Document, 165 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

PGD for the supply of oseltamivir for pre and post exposure prophylaxis of H7N9 avian influenza in adults and children aged one year or older

Ref: UKHSA publications gateway number GOV-10641

MS Word Document, 175 KB

This file may not be suitable for users of assistive technology.

Request an accessible format.
If you use assistive technology (such as a screen reader) and need a version of this document in a more accessible format, please email publications@ukhsa.gov.uk. Please tell us what format you need. It will help us if you say what assistive technology you use.

Details

Oseltamivir for pre and post exposure prophylaxis of non H7N9 avian influenza: PGD template

This PGD template has been developed for use in incidents involving avian influenza strains other than avian influenza A H7N9. The PGD template is to support the supply of oseltamivir for pre and post exposure prophylaxis (PEP) of avian influenza as a public health measure in adults and children aged one year or older. It was reviewed and updated in December 2021. It’s valid from 3 December 2021 until 2 December 2024.

Oseltamivir for post exposure prophylaxis of avian influenza A (H7N9): PGD template

This PGD template has been developed to support the supply of oseltamivir for post exposure prophylaxis of avian influenza A (H7N9) as a public health measure in adults and children aged one year or older.  It was reviewed and updated in December 2021. It’s valid from 3 December 2021 until 2 December 2024.

These PGD templates require further authorisation by a clinical governance or patient safety lead, who has designated responsibility for signing PGDs, so the documents meet legal requirements for PGDs. The PGDs are not legal or valid without this local, formal authorisation.

Adoption and governance of the use of these PGDs is the responsibility of the authorising commissioning body and providers.

Provider organisations and health professionals should check they are working to the current PGD versions and only work to a legally authorised PGD from their commissioning body.

There is also guidance and algorithms for managing avian influenza incidents in birds.

Updates to this page

Published 12 January 2016
Last updated 20 December 2021 + show all updates

  1. Added version 3 of 'PGD for the supply of oseltamivir for pre and post exposure prophylaxis of H7N9 avian influenza in adults and children aged one year or older'.

  2. Updated both PGDs with latest versions.

  3. Replaced 'Oseltamivir for pre and post exposure prophylaxis of non H7N9 and H5N8 avian influenza: PGD template' with 'Oseltamivir for pre and post exposure prophylaxis of non H7N9 avian influenza: PGD template'.

  4. Withdrew the H5N8 patient group directive (PGD).

  5. Updated 2 patient group direction (PGD) templates.

  6. Added new oseltamivir guidance for H7N9 avian flu.

  7. Updated template documents.

  8. Added PGD template for post exposure prophylaxis for Avian Influenza A (H5N8).

  9. Link for Template patient group directions for Avian Influenza incidents has been added.

  10. First published.

Sign up for emails or print this page

Related content